Newsroom

Sorted by: Latest

-

AeroVironment, Inc. to Host Investor Day in New York City, New York on July 8

ARLINGTON, Va.--(BUSINESS WIRE)--AeroVironment, Inc. (“AV”) (NASDAQ: AVAV) will host an investor day in New York City on Wednesday, July 8, 2026. Management presentations and discussions can be viewed that day during a live webcast starting at 5:30 a.m. PT / 6:30 a.m. MT / 7:30 a.m. CT / 8:30 a.m. ET.The event will include presentations from Wahid Nawabi, AV’s chairman, president and chief executive officer; Sean Woodward, senior vice president and chief financial officer; Dr. Rob Smith, chief o...
-

Campbell’s Announces Leadership Transitions in Transformation Office and Communications

CAMDEN, N.J.--(BUSINESS WIRE)--The Campbell’s Company (NASDAQ:CPB) (Campbell’s) — Campbell’s today announced two leadership transitions within its Operating Committee as Dan Poland, Executive Vice President and Chief Enterprise Transformation Officer, and Anthony Sanzio, Executive Vice President and Chief Communications Officer, plan to retire at the end of Campbell’s fiscal year. Melissa Nippert will succeed Poland as Senior Vice President and Chief Transformation Officer, and Beth Jolly will...
-

Quantum to Participate in the Northland Growth Conference on June 23

CENTENNIAL, Colo.--(BUSINESS WIRE)--Quantum Corporation (Nasdaq: QMCO) ("Quantum" or the "Company"), today announced that William White, Chief Financial Officer, will participate virtually at the Northland Securities Growth Conference on Tuesday, June 23, 2026 and will be available to host scheduled conference calls with participating investors throughout the day. Portfolio managers and analysts who would like to request a meeting with management should contact their Northland Securities repres...
-

Franklin Covey to Report Third Quarter Fiscal 2026 Results

SALT LAKE CITY--(BUSINESS WIRE)--Franklin Covey Co. (NYSE: FC), a global leadership and organizational performance partner that gives strategy the human edge, announced today that the conference call to review the Company’s third quarter 2026 financial results will take place on Wednesday, July 1, 2026, at 5:00 p.m. ET (3:00 p.m. MT). The Company’s financial results are expected to be released after the close of the market on Wednesday, July 1, 2026. Interested persons may access a live webcast...
-

Venture Global and EnBW Announce New LNG Purchase Agreements

ARLINGTON, Va.--(BUSINESS WIRE)--Venture Global and EnBW Announce New LNG Purchase Agreements...
-

SS&C ALPS Advisors Announces Share Split of the Barron's 400℠ ETF (BFOR)

DENVER--(BUSINESS WIRE)--SS&C ALPS Advisors announced today that the Board of Trustees of ALPS ETF Trust has approved a 4-for-1 split of the shares of Barron's 400℠ ETF (NYSE Arca: BFOR). The split of BFOR shares will be effective at the market open on July 1, 2026. BFOR will continue to trade on the NYSE Arca under the same ticker symbol. Fund Name Ticker CUSIP Split Ratio Record Date Pay Date Ex-Date Barron's 400 ETF BFOR 00162Q726 4:1 6/29/2026 6/30/2026 7/1/2026 The split will increase...
-

Vehicle Management Solutions Awarded West Virginia Department of Highways Courtesy Patrol Contract

TINLEY PARK, Ill.--(BUSINESS WIRE)--Vehicle Management Solutions (“VMS” or the “Company”), a portfolio company of Mill Point Capital LLC (“Mill Point”), today announced that its Safety Service Patrol (“SSP”) division has been awarded the West Virginia Department of Highways (“WVDOH”) Courtesy Patrol contract, reinforcing VMS’s long-standing role as a trusted partner to public transportation agencies nationwide. VMS brings deep, institutional experience operating West Virginia’s statewide Courte...
-

Corcept Resubmits New Drug Application for Relacorilant as a Treatment for Patients with Cushing’s Syndrome

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced it has resubmitted its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for relacorilant as a treatment for patients with Cushing’s syndrome.As requested by t...
-

Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)

PHILADELPHIA--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) and Spero Therapeutics (Nasdaq: SPRO) today announced that the US Food and Drug Administration (FDA) has approved Utebzi, an oral antibiotic for the treatment of complicated urinary tract infections (cUTIs) including pyelonephritisi, caused by certain susceptible pathogensii in adult patients who have limited or no alternative oral treatment options. This is the first and only oral carbapenem antibiotic approved for these patients. This app...
-

Opsin Leads the Second Generation of Enterprise AI Security as Agents Move from Saying to Doing

SAN FRANCISCO--(BUSINESS WIRE)--Marquee customer wins, analyst recognition, and platform innovation underscore Opsin's leadership in governance for autonomous enterprise agents....